Zacks Investment Research on MSN
JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?
Johnson & Johnson JNJ and Merck MRK are leading U.S. healthcare giants, making them natural peers for a head-to-head ...
Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...
Although the revenue and EPS for Ionis Pharmaceuticals (IONS) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare ...
Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Alnylam Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
A rally in healthcare stocks was propelling the growth-heavy Nasdaq Composite and the S&P 500 toward their highest levels of ...
Pharmaceutical concern Eli Lilly And Co (NYSE:LLY ) is charging 7.2% higher to trade at $821.20 this afternoon. Starting today, President Trump imposed a 100% tariff on branded or patented ...
Zacks Investment Research on MSN
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year increase in earnings on higher revenues when it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback